trial

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

NCTId NCT00541996
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment —
Sponsored by Wyeth is now a wholly owned subsidiary of Pfizer
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
—
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2007-08
Primary completion
—
Eligibility
MALE · 18 Years · 50 Years

Interventions & indications

Drugs
vabicaserin

Sponsors

Wyeth is now a wholly owned subsidiary of PfizerLead Sponsor

Sites

0 total

Facts & assertions

2 sourced
Phase
PHASE1
Status
COMPLETED
relationships
The graph out of here
drug
vabicaserin
drug
lead_sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
company
indication
Schizophrenia
indication
Schizophrenia
indication